热门资讯> 正文
Nanobiotix任命新首席财务官
2026-10-02 04:37
- Nanobiotix (NBTX) said on Thursday that it appointed Arnd Christ as chief financial officer and member of the company’s executive board, effective October 1, 2026.
- Christ succeeds Bart Van Rhijn, who stepped down after five years of service to the company.
- Christ brings more than two decades of financial leadership in publicly listed biotechnology companies in Europe and the United States.
- Shares of Nanobiotix closed 10.46% down.
- Press Release
More on Nanobiotix
- Seeking Alpha’s Quant Rating on Nanobiotix
- Historical earnings data for Nanobiotix
- Financial information for Nanobiotix
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。